RxAll Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 21

RxAll General Information

Description

Developer of a deep learning hyperspectral IoT platform designed for authenticating drugs in real time. The company's platform works through spectrometers and a cloud dataset of spectral signatures of medicines to carry out non-destructive product authentication, enabling pharma manufacturers to get information in real time about counterfeiting of their products and making high-quality medicines accessible to everyone at affordable prices.

Contact Information

Website
www.rxall.net
Formerly Known As
RxAllng, RxAll NG
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 165 Whitney Avenue
  • New Haven, CT 06511
  • United States
+1 (415)
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Other Healthcare Technology Systems
Other Devices and Supplies
Corporate Office
  • 165 Whitney Avenue
  • New Haven, CT 06511
  • United States
+1 (415)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RxAll Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Later Stage VC 01-Sep-2026 Completed Generating Revenue
14. Accelerator/Incubator 30-Apr-2025 Completed Generating Revenue
13. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
12. Seed Round 25-Oct-2021 Completed Generating Revenue
11. Seed Round 02-Jun-2021 Completed Generating Revenue
10. Seed Round 10-Nov-2020 Completed Generating Revenue
9. Seed Round 21-Sep-2020 Completed Generating Revenue
8. Accelerator/Incubator 01-Jan-2020 Completed Generating Revenue
7. Accelerator/Incubator 16-Oct-2019 $1.1M Completed Generating Revenue
6. Grant 28-Mar-2019 $113K $1.1M Completed Generating Revenue
To view RxAll’s complete valuation and funding history, request access »

RxAll Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-1
Series A-2 Seed
Seed-5
Seed-4
Seed-3 1,877,035 $0.000100 $0.48 $0.48 1x $0.48 8.67%
Seed-2 444,016 $0.000100 $0.32 $0.32 1x $0.32 2.05%
To view RxAll’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

RxAll Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RxAll Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds
FIVE35 Ventures Venture Capital Minority
Investing in Innovation Accelerator/Incubator
Harvard Innovation Launch Lab Accelerator/Incubator
Fondation Botnar Not-For-Profit Venture Capital Minority
LoftyInc Capital Management Venture Capital Minority
You’re viewing 5 of 21 investors. Get the full list »

RxAll FAQs

  • When was RxAll founded?

    RxAll was founded in 2016.

  • Where is RxAll headquartered?

    RxAll is headquartered in New Haven, CT.

  • What is the size of RxAll?

    RxAll has 20 total employees.

  • What industry is RxAll in?

    RxAll’s primary industry is Enterprise Systems (Healthcare).

  • Is RxAll a private or public company?

    RxAll is a Private company.

  • What is RxAll’s current revenue?

    The current revenue for RxAll is .

  • How much funding has RxAll raised over time?

    RxAll has raised $5.8M.

  • Who are RxAll’s investors?

    FIVE35 Ventures, Investing in Innovation, Harvard Innovation Launch Lab, Fondation Botnar, and LoftyInc Capital Management are 5 of 21 investors who have invested in RxAll.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process